CSL Seqirus, the vaccine unit of Australian biotech CSL, signed a pact to provide Saudi Arabia with cell-based influenza shots and to help establish its production in-country. The move comes as part of an effort to boost domestic manufacturing and pandemic preparedness in the oil-rich kingdom.
CSL Seqirus strikes flu shot supply, production pact with Saudi Arabia
Latest from Blog
NNB Nutrition Showcased Next-Generation Sweeteners, Naturally Occurring Dipeptides, Ultra-Pure Creatine and Fermented Actives at SupplySide Global 2026
/PRNewswire/ — NNB Nutrition, the ingredient company behind the tagline “Pure. Potent. Precise Ingredients,” showcased its latest innovations at SupplySide… Post Views: 1
Multivitamin for Women Market Forecast to 2035, Driven by Personalized Nutrition Demand
The multivitamin for women market is set to expand through 2035, supported by rising demand for personalized nutrition and life-stage-specific formulations. Post Views: 2
The Research Hehind ApplePhenon
Post Views: 1
Cultivated wagyu beef gains UK pet food approval
Ivy Farm Technologies can now supply its cultivated wagyu beef to U.K. pet food brands, with its first commercial-scale production run expected to be completed in early 2027. Post Views: 1
Amino Acid Premixes Market Forecast to 2035: Demand Accelerates on Precision Livestock Feeding and Human Nutrition
The global amino acid premixes market is set to expand through 2035, driven by precision livestock feeding and rising demand for tailored human nutrition solutions. Post Views: 1